ALIVUS.NS(ALIVUS.NS)
ALIVUS.NS
No analyst ratings available
No analyst price targets available for ALIVUS.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $28.21B | $31.33B | $35.03B |
| Low | $28.07B | $31.19B | $34.95B |
| High | $28.30B | $31.54B | $35.10B |
| EBITDA Avg | $8.86B | $9.84B | $11.01B |
| Low | $8.82B | $9.80B | $10.98B |
| High | $8.89B | $9.91B | $11.03B |
| EBIT Avg | $8.09B | $8.98B | $10.04B |
| Low | $8.05B | $8.94B | $10.02B |
| High | $8.11B | $9.04B | $10.06B |
| Net Income Avg | $6.66B | $7.55B | $8.87B |
| Low | $6.59B | $7.48B | $8.83B |
| High | $6.72B | $7.63B | $8.91B |
| EPS Avg | $54.20 | $61.60 | $72.10 |
| Low | $53.58 | $60.82 | $71.80 |
| High | $54.66 | $62.02 | $72.45 |
| Analysts (Rev / EPS) | 3 / 2 | 4 / 3 | 2 / 1 |